Transactions under Novozymes’ stock buyback program

As of August 14, Novozymes has purchased an accumulated 4,635,141 shares with a transaction value of DKK 1,197.4 million under the stock buyback program Novozymes announced in Company announcement No. 17, 2014 and initiated February 17, 2014.

Under the program, Novozymes will buy back B shares worth up to DKK 2 billion in total during 2014.

The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:       

 
Number
 of shares
Average
purchase price
Transaction
value, DKK
Accumulated, last announcement
4,444,820
 
1,145,904,719
August 8, 2014
47,730
265.49
12,671,649
August 11, 2014
37,668
 274.75
10,349,358
August 12, 2014
45,783
275.16
12,597,520
August 13, 2014
32,140
 276.59
8,889,732
August 14, 2014
27,000
260.24
7,026,403
Total accumulated under the program
4,635,141
 
1,197,439,381
In addition, transactions necessitated by Novozymes’ previously established incentive programs have resulted in a net sale by Novozymes of 4,775 B shares in the period from August 8 to August 14, 2014. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
 
Following the transactions stated above, Novozymes owns a total of 8,734,497 treasury shares, corresponding to 2.7% of the stock capital. The total number of shares in the company is 319,700,000, including treasury shares.
Contact information
Investor Relations:
 
 
Thomas Bomhoff (DK)
+45 3077 1226
Klaus Sindahl (DK)
+45 5363 0134
Martin Riise (USA)
+1 919 649 2565
Press and media:
 
 
Rene Tronborg (DK)
+45 3077 2274
Frederik Bjoerndal (Europe)
+44 7976138265
Paige Donnelly (USA)
+1 919 218 4501
Meng Lian (China)
+86 136 9923 1164
Henrique Pellini (Brazil)
+55 41 9288 0282
Poonam Kapila (India)
+91 991 082 2339